Skip to content
GenoLensGenoLens

GH1

Chr 17q23.3

growth hormone 1

Aliases:
hGH, GH-N, GHN, GH, hGH-N
MANE:
ENST00000323322.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • IUGR and IGF abnormalities

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Monogenic short stature

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Pituitary hormone deficiency

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Osteogenesis imperfecta

Disease associations (Open Targets)

  • Non-acquired isolated growth hormone deficiency

    0.81
  • isolated growth hormone deficiency type II

    0.75
  • isolated growth hormone deficiency type IB

    0.74
  • short stature due to growth hormone qualitative anomaly

    0.69
  • isolated growth hormone deficiency type IA

    0.60
  • hereditary disease

    0.42
  • neurodegenerative disease

    0.34
  • Decreased response to growth hormone stimulation test

    0.19
  • acromegaly

    0.13
  • Prader-Willi syndrome

    0.12

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Somatotropin

Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.